Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor.
- 1 January 1993
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (1) , 198-202
- https://doi.org/10.1073/pnas.90.1.198
Abstract
Human umbilical vein endothelial cells (HUVECs) produce a property that impairs the generation of coagulant and amidolytic activity initiated when normal human plasma is exposed to glass. This inhibitory property blocks the adsorption of Hageman factor (factor XII) to glass, thereby preventing the activation of Hageman factor, but does not impair the coagulant or amidolytic activity of already activated Hageman factor (factor XIIa). This property in HUVEC lysates could be neutralized by a purified preparation of Hageman factor but not by purified prekallikrein or high molecular mass kininogen. A partially purified inhibitory fraction from cell lysates exhibited a single homogeneous band in SDS/PAGE of approximately 22.5 kDa. Inhibitory activity was also found in concentrates of conditioned media from HUVECs, which also impaired the binding of Hageman factor to a surface; it may not be identical with that found in cell lysates.Keywords
This publication has 27 references indexed in Scilit:
- Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta.The Journal of cell biology, 1990
- Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells.Journal of Clinical Investigation, 1987
- Inhibition of the activation of Hageman factor (factor XII) by complement subcomponent C1q.Journal of Clinical Investigation, 1987
- Human C.hivin.1 inhibitor: primary structure, cDNA cloning, and chromosomal localizationBiochemistry, 1986
- Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cellsBiochemical and Biophysical Research Communications, 1985
- Bovine aortic endothelial cells elaborate an inhibitor of the generation of lipopolysaccharide-stimulated human blood monocyte procoagulant activity.Journal of Clinical Investigation, 1984
- Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.Journal of Clinical Investigation, 1982
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.Journal of Clinical Investigation, 1977
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973